Psyence Biomedical Ltd.
PBMWW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001985062
No open-market purchases or sales by Psyence Biomedical Ltd. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $121.6K in total; no superinvestor holds it.
Other share classesPBM
13F holders, Q4 2024
Institutional positions in Psyence Biomedical Ltd. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −1 vs. Q3 2024
- Shares held
- 5.74M
- −553.7K (−8.8%) vs. Q3 2024
- Total value
- $80.2K
- +$937 (+1.2%) vs. Q3 2024
- New holders
- 3
- 2 more added
- Sold out
- 4
- 3 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PBMWW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $121.6K |
| Q1 2026 | 19 | $96.6K |
| Q4 2025 | 21 | $101.1K |
| Q3 2025 | 23 | $142.4K |
| Q2 2025 | 23 | $123.8K |
| Q1 2025 | 23 | $96.4K |
| Q4 2024 | 22 | $80.2K |
| Q3 2024 | 23 | $79.2K |
| Q2 2024 | 28 | $71.9K |
| Q1 2024 | 30 | $499.9K |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Psyence Biomedical Ltd.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Harraden Circle Investments, LLC | 1,150,000 | $16.6K | 0.01% | +1,150,000 | New |
| Polar Asset Management Partners Inc. | 733,000 | $10.6K | 0.00% | 00.0% | Unchanged |
| MMCAP International Inc. SPC | 600,000 | $8.64K | 0.00% | 00.0% | Unchanged |
| Calamos Advisors LLC | 500,000 | $6.15K | 0.00% | 00.0% | Unchanged |
| Cantor Fitzgerald, L. P. | 468,500 | $5.62K | 0.00% | 00.0% | Unchanged |
| Saba Capital Management, L.P. | 297,847 | $4.14K | 0.00% | 00.0% | Unchanged |
| Aristeia Capital LLC | 272,857 | $3.79K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 200,117 | $2.88K | 0.00% | 00.0% | Unchanged |
| Periscope Capital Inc. | 200,000 | $2.88K | 0.00% | −25,000−11.1% | Reduced |
| LMR Partners LLP | 200,000 | $2.88K | 0.00% | +200,000 | New |
| Clear Street LLC | 180,566 | $2.60K | 0.00% | +140+0.1% | Added |
| Tenor Capital Management Co., L.P. | 150,000 | $2.16K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 175,352 | $2.16K | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 147,101 | $2.12K | 0.00% | 00.0% | Unchanged |
| Clear Street Derivatives LLC | 109,356 | $1.57K | 0.00% | −168,563−60.7% | Reduced |
| Westchester Capital Management, LLC | 92,073 | $1.13K | 0.00% | 00.0% | Unchanged |
| Yakira Capital Management, Inc. | 76,843 | $1.11K | 0.00% | 00.0% | Unchanged |
| Mint Tower Capital Management B.V. | 50,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 50,551 | $1.00K | 0.00% | +50,551 | New |
| Walleye Trading LLC | 44,080 | $635 | 0.00% | +19,726+81.0% | Added |
| Walleye Capital LLC | 34,282 | $494 | 0.00% | −164,014−82.7% | Reduced |
| Ancora Advisors, LLC | 5,000 | $72 | 0.00% | 00.0% | Unchanged |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −1,220,986−100.0% | Sold out |
| Context Capital Management, LLC | 0 | $0 | 0.00% | −234,200−100.0% | Sold out |
| Shaolin Capital Management LLC | 0 | $0 | 0.00% | −148,809−100.0% | Sold out |
| Anson Funds Management LP | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |